肺癌肿瘤中的“关闭开关”或解释免疫治疗对部分患者无效的原因
Overlooked 'off switch' in lung tumors may explain why immunotherapy doesn't work for everyone
Jackson实验室团队在《科学》杂志发表研究,发现肺癌通过RNA替代剪接产生不同版本的STAT2基因,而非基因突变来削弱其功能。基于两项大型临床数据分析,带有内含子保留的STAT2 RNA剪接特征与阿替利珠单抗免疫治疗后患者生存期延长相关。
研究通过RNA剪接机制识别免疫治疗应答标志,为肺癌精准用药提供新思路。
An overlooked mechanism in lung cancer tumors may help explain why most patients don't respond to immunotherapy, according to new research led by Olga Anczuków, professor at The Jackson Laboratory for Genomic Medicine in Farmington, Connecticut, and deputy director of the NCI-designated Jackson Laboratory Cancer Center.
The JAX team includes co-senior author Karolina Palucka, professor and director of the NCI-designated Jackson Laboratory Cancer Center, and Ryan P. Englander, the study's first author and a graduate student at The Jackson Laboratory enrolled in the UConn Health MD-Ph.D. graduate program.
Published in Science, the study shows that lung tumors can disable a key gene called STAT2, not through mutations, but instead by altering how its RNA instructions are processed through a mechanism known as RNA splicing. Using long-read RNA sequencing, the team discovered thousands of previously unrecognized RNA variants in lung tumors.
Based on an analysis of two large clinical trials of the immunotherapy drug atezolizumab, specific STAT2 RNA splicing patterns were associated with longer survival after immunotherapy. Most reference databases used in cancer research and testing do not include these newly discovered splicing patterns.
The researchers have filed a provisional patent application for correcting this splicing mistake with RNA-based drugs, as well as for predicting immunotherapy response.
Publication details
Ryan P. Englander et al., Intron retention regulates STAT2 function and associates with immunotherapy response in lung cancer, Science (2026). DOI: 10.1126/science.aea7156
Journal information: Science
Clinical categories
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Overlooked 'off switch' in lung tumors may explain why immunotherapy doesn't work for everyone (2026, October 23) retrieved 23 October 2026 from https://medicalxpress.com/news/2026-10-overlooked-lung-tumors-immunotherapy-doesnt.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com